Literature DB >> 11788912

Erotomania revisited: clinical course and treatment.

N Kennedy1, M McDonough, B Kelly, G E Berrios.   

Abstract

Erotomania is a rare disorder in which an individual has a delusional belief that a person of higher social status falls in love and makes amorous advances towards him/her. Little is known about the background, classification, treatment, or outcome of individuals with this disorder. The purpose of this study was to evaluate current criteria for diagnosing and classifying primary and secondary erotomania in addition to examining course, outcome, and impact on victims of erotomania. Semistructured interviews covering personal and family details in addition to treatment and outcome to date were performed on a series of erotomanic patients identified in a defined area. Evaluation of diagnosis used DSM-IV and other criteria. Fifteen erotomanic subjects (11 female, four male) were identified. Most were isolated, without a partner or full-time occupation. Forty percent had a first-degree relative with a psychiatric history and of those half had a first-degree relative with a mono-delusional disorder. Less than half of the objects of their affection, mainly noncelebrities, were subject to harassment. Subjects with primary erotomania and erotomania secondary to other psychiatric diagnoses were identified using DSM-IV criteria. Ellis and Mellsop's criteria were found to be useful in assessing erotomania but we could not replicate Seeman's fixed and recurrent groups. Treatment and outcome was better than expected particularly for those with primary erotomania and erotomanics with a diagnosis of bipolar affective disorder. In this series, erotomanic symptoms largely occurred in the context of other psychiatric disorders, although subjects with pure erotomanic symptoms were seen. Subjects were less dangerous and engaged in less harassment of victims than the literature suggests. Subjects were often isolated, unemployed, and with few social contacts. Strong family psychiatric histories were seen particularly with regard to mono-delusional disorders raising the possibility of genetic inheritance. An adaptation of Ellis and Mellsop's criteria was suggested for the diagnosis of primary and secondary erotomania. Response to treatment and prognosis was good, particularly for primary erotomania and erotomania secondary to bipolar affective disorder. Copyright 2002 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788912     DOI: 10.1053/comp.2002.29856

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

Review 1.  Schizophrenia and monothematic delusions.

Authors:  Max Coltheart; Robyn Langdon; Ryan McKay
Journal:  Schizophr Bull       Date:  2007-03-19       Impact factor: 9.306

Review 2.  Erotomania : epidemiology and management.

Authors:  Brendan D Kelly
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Erotomania revisited: thirty-four years later.

Authors:  Harold W Jordan; Edna W Lockert; Marjorie Johnson-Warren; Courtney Cabell; Tiffany Cooke; William Greer; Gary Howe
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

4.  Fictosexuality, Fictoromance, and Fictophilia: A Qualitative Study of Love and Desire for Fictional Characters.

Authors:  Veli-Matti Karhulahti; Tanja Välisalo
Journal:  Front Psychol       Date:  2021-01-12

Review 5.  Erotomania and phenotypic continuum in a family frameshift variant of AUTS2: a case report and review.

Authors:  Christophe Gauld; Alice Poisson; Julie Reversat; Elodie Peyroux; Françoise Houdayer-Robert; Massimiliano Rossi; Gaetan Lesca; Damien Sanlaville; Caroline Demily
Journal:  BMC Psychiatry       Date:  2021-07-17       Impact factor: 3.630

Review 6.  If I could just stop loving you: anti-love biotechnology and the ethics of a chemical breakup.

Authors:  Brian D Earp; Olga A Wudarczyk; Anders Sandberg; Julian Savulescu
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.